Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats

BMC Complementary and Alternative Medicine

Chuan-yun Qian²  Mao-li Tian¹  Xu Liu¹  Lan-fang Qin¹  Wei Wei²  Yun-hui Wang²  Mei-xian Su³  Ming-wei Liu² 

[1] Department of Infectious Diseases, Yan’an Hospital Affiliated to Kunming Medical University, 245 Renmin Eastern Road, Pan Long District, Kunming 650051, China;Department of Emergency, The First Hospital Affiliated To Kunming Medical University, 295 Xichang Road, Wu Hua District, Kunming 650032, China;Intensive Care Unit, The Second Hospital Affiliated To Kunming Medical University, 1 Mayuan, Wu Hua District, Kunming 650106, China

关键词: Rats;    Cecal ligation and puncture;    Cannabinoid receptors;    Melilotus extract;    Sepsis;   

Others  :  1220229
DOI  :  10.1186/1472-6882-14-94

 received in 2013-06-30, accepted in 2014-02-24,  发布年份 2014

【 摘 要 】

Background

M. Suaveolens Ledeb has long been used in China to treat inflammatory infectious diseases. Melilotus is extracted from Melilotus Suaveolens Ledeb and its therapeutic potential is associated with its anti-inflammatory activity. However, the precise mechanisms underlying its effects are unknown. This study was conducted to evaluate the protective effects of melilotus extract in a rat cecal ligation and puncture (CLP)-induced animal model of acute lung injury (ALI).

Methods

A sepsis model was induced by CLP-like lung inflammation. Two hours prior to CLP administration, the treatment group was administered melilotus extract via oral injection. RT-PCR and Western blotting were used to test the expression of cannabinoid receptor (CB)2, NF-κβ and IκB from single peripheral blood mononuclear cells and lung tissues respectively. Enzyme linked immune sorbent assay was used to detect serum levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-10, and IL-12. The numbers of neutrophils, lymphocytes, macrophages and total cells in the bronchoalveolar lavage (BAL) fluid were counted. For histologic analysis, hematoxylin and eosin (H&E) stains were evaluated.

Results

After inducing ALI by CLP for 24 hours, melilotus extract up-regulated peripheral blood mononuclear cell CB2 expression, blocked the activity of NF-κβ65, and the number of neutrophils, lymphocytes and total cells were significantly lower in the melilotus extract group than the control group. In addition, TNF-α and IL-6 levels were significantly decreased in the melilotus extract group. Histological results demonstrated the attenuation effect of melilotus extract on CLP-induced lung inflammation. CB2 was negatively correlated to NF-κβ mRNA and proteins, respectively (r = -0.377, P < 0.05; r = -0.441, P < 0.05).

Conclusion

The results of this study indicated melilotus extract significantly reduced CLP-induced lung inflammation by up-regulating CB2 expression. The remarkable protective effects of melilotus extract suggest its therapeutic potential in CLP induced-acute lung injury treatment.

【 授权许可】

   
2014 Liu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

【 参考文献 】

• [1]Lee YS, Kim SY, Kwon CW, Song HG, Lee YK, Kim HJ: Two cases of systemic capillary leak syndrome that were treated with pentastarch. Korean J Intern Med 2007, 22:130-132.
• [2]Zhao L, Tao JY, Zhang SL, Jin F, Pang R, Dong JH: N-butanol Extract from Melilotus Suaveolens Ledeb Affects Pro- and Anti-Inflammatory Cytokines and Mediators. Evid Based Complement Alternat Med 2010, 7:97-106.
• [3]Galiègue S, Mary S, Marchand J, Dussossoy D, Carrière D, Wang Z: Expression of central and peripheral can nabinoid receptors inhuman immune tissues and leukocyte subpopulations. Eur J Biochem 1995, 232:54-61.
• [4]Kieman JA: Histologic and histochemical. In Theory and practice. 4th edition. Bloxham, UK: Scion; 2008.
• [5]Kruger NJ: The Bradford method for protein quantitation. In The protein protocois handbook. Edited by Walker J. Hatfield UK: University of Herfordshire; 2002:15-21.
• [6]Seely KA, Holthoff JH, Burns ST, Wang Z, Thakali KM, Gokden N, Rhee SW, Mayeux PR: Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 2011, 301:F209-F217.
• [7]Sichuan Ganzi Institute for Drug Control: Melilotus suaveolens Ledeb. In Drug Standard of Ministry of Health of the People’s Republic of China (Tibetan Medicine). Volume 1. Edited by China Pharmacopoeia Committee. Beijing: People’s Medical Publishing House; 1995::65.
• [8]Qi LW, Yu QT, Li P, Li SL, Wang YX, Sheng LH, Yi L: Quality evaluation of Radix astragali through a simultaneous determination of six major active isoflavonoids and four main saponins by highperformance liquid chromatography coupled with diode array and evaporative light scattering detectors. J Chromatogr A 2006, 1134:162-169.
• [9]Ziring D, Wei B, Velazquez P, Schrage M, Buckley NE, Braun J: Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics 2006, 58:714-725.
• [10]Ritter C, Andrades M, Frota Júnior ML, Bonatto F, Pinho RA, Polydoro M, Klamt F, Pinheiro CT, Menna-Barreto SS, Moreira JC, Dal-Pizzol F: Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med 2003, 29:1782-1789.
• [11]Uji Y, Yamamoto H, Tsuchihashi H, Maeda K, Funahashi T, Shimomura I, Shimizu T, Endo Y, Tani T: Adiponectin deficiency is associated with severe polymicrobial sepsis, high inflammatory cytokine levels, and high mortality. Surgery 2009, 145:550-557.
• [12]Bello GM, Frevert CW, Martin TR: Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008, 295:379-397.
• [13]Kunos G, László SB, Offertáler L, Mo F, Liu J, Karcher J, Harvey-White J: The quest for a vascular endothelial cannabinoid receptor. Chem Phys Lipids 2002, 121:45-56.
• [14]Romero-Sandoval A, Nutile-McMenemy N, DeLeo JA: Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology 2008, 108:722-734.
• [15]Romero-Sandoval A, Eisenach JC: Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiology 2007, 106:787-794.
• [16]Held-Feindt J, Dörner L, Sahan G, Mehdorn HM, Mentlein R: Cannabinoid receptors in human astroglial tumors. J Neurochem 2006, 98:886-893.
• [17]Stebulis JA, Johnson DR, Rossetti RC, Burstein SH, Zurier RB: Ajulemic acid, asynthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells. Life Sci 2008, 83:666-670.
• [18]Rajesh M, Mukhopadhyay P, Haskó G, Huffman JW, Mackie K, Pacher P: CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothe lia lm-igration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol 2007, 293:H2210-H2218.
• [19]Ramos G, Limon-Flores AY, Ullrich SE: JP-8 induces immune suppression via a reactive oxygen species NF-κβ–dependent mechanism. Toxicol Sci 2009, 108:100-109.
• [20]Huang Y, Nikolic D, Pendland S, Doyle B, Locklear T, Mahady G: Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-κβ transcriptional response in vitro. Pharm Biol 2009, 47:18-25.
• [21]Zingarelli B, Sheehan M, Hake PW, Connor MO, Denenberg A, Cook JA: Peroxisome Proliferator Aetivator Receptor-γ Ligands,15-Deoxy-△12,14- Prostaglandin J2 and Cigitazone, reduce systemic inflammnationin polymierobial sepsis by modulation of signal transduction pathways. J Immunol 2003, 171:6827-6837.
• [22]Guo XH, Pan YF, Xiao CY, Wu YQ, Cai DZ, Gu JR: Fractalkine stimulates cell growth and increases its expression via NF-κB pathway in RA-FLS. Int J Rheum Dis 2012, 15:322-329.
• [23]Gebre MT, Asres K, Getie M, Endale A, Neubert R, Schmidt PC: In vitro availability of kaempferol glycosides from cream formulations of methanol extract of the leaves of Melilotus elegans. Eur J Pharm Biopharm 2005, 60:31-38.
• [24]Saxena VK, Nigam S: Antifungal studies of pterocarponoids from Melilotus indica. Asian J Chem 1996, 8:337-338.
• [25]Foidi M, Zoltan OI: Learning ability in experimental lymphogenic encephalopathy under the influence of coumarin from Melilotus officinalis. Arzneimittelforschung 1970, 20:1614-1635.
• [26]Kang SS, Lee YS, Lee EB: Saponins and flavonoid glycosidesfrom yellow sweet clover. Arch Pharm Res 1988, 11:197-202.
• [27]Asres K, Gibbons S, Nachname , Vorname : Anti-inflammatory activity of extracts and a saponin isolated from melilotu selegans. Pharmazie 2005, 60:310-312.
• [28]Plesca-Manea L, Parvu AE, Parvu M, Tarmak M, Buia R, Puia M: Effects of Melilotusofficinalis on acute inflammation. Phytother Res 2002, 16:316.
• [29]Ritschel WA, Brady ME, Tan HIS, Hoffmann KA, Yiu MI, Grummich KW: Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man. Eur J Clin Pharmacol 1977, 12:457-461.
• [30]Tao JY, Zheng GH, Zhao L, Wu JG, Zhang XY, Zhang SL, Huang ZJ, Xiong FL, Li CM: Anti-inflammatory effects of ethylacetate fraction from melilotus suaveolens Ledeb on LPS-stimulated RAW 264.7 cells. Ethnopharmacol 2009, 123:97-105.